GMED in the 13F filings

Globus Medical Inc · CUSIP 379577208

Sector · Medical devices and instruments Theme · Healthcare: biopharma and medtech· L3VLUP-defined Theme · Surgical, medical and electromedical devices

Quarter

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Quarter end: 30 Jun 2026; the date the book describes
Filed: 27 Oct 2026; latest of these filings; the earliest 3 Aug 2026
Managers listing it: 26; at least, of 95 tracked, among listed positions
Comparable managers: 91; filed both Q1 2026 and Q2 2026; 11 listed it in both
Shares listed: 20,976,634; combined, among listed positions
Reported value: $1.7bn; combined, at the quarter end

AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.

Among the 91 comparable managers: 14 buyers (opened or added shares) and 18 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -2,547,025.

Managers listing GMED in Q2 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2026, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

ActionShare of book at least

26 of 26 holders

				Action		Filing
Janus Henderson Group Ltd	8,200,423	$648m	0.26%	Added	+577,328	14 Aug 2026 (the filing on sec.gov)
Invesco Ltd	4,309,771	$341m	under 0.1%	Trimmed	-6,883	14 Aug 2026 (the filing on sec.gov)
AllianceBernstein LP	2,380,344	$205m	0.07%	Added	+629,512	14 Aug 2026 (the filing on sec.gov)
Arrowstreet Capital LP	1,716,621	$136m	0.06%	Added	+803,716	13 Aug 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc	951,956	$75m	under 0.1%	Added	+351,791	14 Aug 2026 (the filing on sec.gov)
Fidelity (FMR LLC)	768,051	$61m	under 0.1%	Added	+167,595	13 Aug 2026 (the filing on sec.gov)
Capital World Investors	590,612	$47m	under 0.1%	Added	+16,112	12 Aug 2026 (the filing on sec.gov)
Holocene Advisors LP	399,932	$32m	0.07%	Trimmed	-373,902	14 Aug 2026 (the filing on sec.gov)
Bridgewater Associates LP	351,974	$28m	0.11%	Added	+21,511	14 Aug 2026 (the filing on sec.gov)
Woodline Partners LP	226,640	$18m	0.06%	Added	+158,232	14 Aug 2026 (the filing on sec.gov)
Renaissance Technologies LLC	196,918	$16m	under 0.1%	New	new	13 Aug 2026 (the filing on sec.gov)
Marshall Wace LLP	188,541	$15m	under 0.1%	Trimmed	-374,089	13 Aug 2026 (the filing on sec.gov)
MFS Investment Management	177,598	$14m	under 0.1%	Trimmed	-56,153	3 Aug 2026 (the filing on sec.gov)
Walleye Capital LLC	156,421	$12m	under 0.1%	Added	+156,394	3 Aug 2026 (the filing on sec.gov)
GAMCO Investors Inc	129,217	$10m	0.09%	Trimmed	-38	12 Aug 2026 (the filing on sec.gov)
Man Group PLC	55,320	$4.4m	under 0.1%	Added	+13,852	14 Aug 2026 (the filing on sec.gov)
AQR Capital Management LLC	36,534	$2.9m	under 0.1%	Trimmed	-810,244	14 Aug 2026 (the filing on sec.gov)
Wellington Management Group LLP	35,066	$2.8m	under 0.1%	Added	+4,851	14 Aug 2026 (the filing on sec.gov)
Millennium Management LLC	28,835	$2.3m	under 0.1%	Trimmed	-1,614,517	14 Aug 2026 (the filing on sec.gov)
Brevan Howard Capital Management LP	19,565	$1.5m	under 0.1%	Added	+15,395	14 Aug 2026 (the filing on sec.gov)
Susquehanna International Group LLP	17,702	$1.4m	under 0.1%	Added	+2,499	14 Aug 2026 (the filing on sec.gov)
Neuberger Berman Group LLC	13,214	$1.0m	under 0.1%	Trimmed	-561	27 Oct 2026 (the filing on sec.gov)
D. E. Shaw & Co.	8,300	$656k	under 0.1%	Trimmed	-20,059	14 Aug 2026 (the filing on sec.gov)
Ruane Cunniff & Goldfarb LP	6,008	$475k	under 0.1%	Held	0	14 Aug 2026 (the filing on sec.gov)
Acadian Asset Management LLC	5,773	$454k	under 0.1%	Trimmed	-4,481	13 Aug 2026 (the filing on sec.gov)

Page 1 of 2

Largest increases and reductions, by shares

Q1 2026 to Q2 2026, among managers that listed it in both quarters or opened it.

Increases

Arrowstreet Capital LPexisting position · 1,716,621 shares now+803,716
AllianceBernstein LPexisting position · 2,380,344 shares now+629,512
Janus Henderson Group Ltdexisting position · 8,200,423 shares now+577,328
T. Rowe Price Associates Incexisting position · 951,956 shares now+351,791
Renaissance Technologies LLCnew position · 196,918 shares now+196,918

Reductions

Millennium Management LLCexisting position · 28,835 shares now-1,614,517
AQR Capital Management LLCexisting position · 36,534 shares now-810,244
Marshall Wace LLPexisting position · 188,541 shares now-374,089
Holocene Advisors LPexisting position · 399,932 shares now-373,902
Jane Street Group LLCexisting position · 5,298 shares now-93,813

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Renaissance Technologies LLC$16m

Exited (7)

Citadel Advisors LLCwas $169m
ExodusPoint Capital Management LPwas $18m
Balyasny Asset Management LLCwas $5.5m
Verition Fund Management LLCwas $3.9m
Maverick Capital Ltdwas $1.3m
Quantbot Technologies LPwas $349k
Farallon Capital Management LLCwas $345k

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.

12 in Q3 2024 to 10 in Q2 2026

Tracked managers listing it, at least.

the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.

GMED by quarter
Quarter	Holders	Reported value	Buyers	Sellers
Q2 2013	2	$32m	n.a.	n.a.
Q3 2013	2	$131m	n.a.	n.a.
Q4 2013	2	$154m	n.a.	n.a.
Q1 2014	2	$188m	n.a.	n.a.
Q2 2014	6	$144m	n.a.	n.a.
Q3 2014	4	$134m	n.a.	n.a.
Q4 2014	4	$136m	n.a.	n.a.
Q1 2015	3	$154m	n.a.	n.a.
Q2 2015	4	$195m	n.a.	n.a.
Q3 2015	5	$155m	n.a.	n.a.
Q4 2015	2	$215m	n.a.	n.a.
Q1 2016	4	$194m	n.a.	n.a.
Q2 2016	3	$200m	n.a.	n.a.
Q3 2016	3	$215m	n.a.	n.a.
Q4 2016	4	$232m	n.a.	n.a.
Q1 2017	4	$233m	n.a.	n.a.
Q2 2017	2	$266m	n.a.	n.a.
Q3 2017	5	$341m	n.a.	n.a.
Q4 2017	5	$482m	n.a.	n.a.
Q1 2018	7	$588m	n.a.	n.a.
Q2 2018	7	$513m	n.a.	n.a.
Q3 2018	13	$674m	n.a.	n.a.
Q4 2018	13	$570m	n.a.	n.a.
Q1 2019	5	$619m	n.a.	n.a.
Q2 2019	5	$589m	n.a.	n.a.
Q3 2019	6	$733m	n.a.	n.a.
Q4 2019	12	$832m	n.a.	n.a.
Q1 2020	7	$597m	n.a.	n.a.
Q2 2020	6	$610m	n.a.	n.a.
Q3 2020	8	$639m	n.a.	n.a.
Q4 2020	6	$855m	n.a.	n.a.
Q1 2021	7	$779m	n.a.	n.a.
Q2 2021	10	$997m	n.a.	n.a.
Q3 2021	9	$871m	n.a.	n.a.
Q4 2021	10	$912m	n.a.	n.a.
Q1 2022	10	$934m	n.a.	n.a.
Q2 2022	7	$684m	n.a.	n.a.
Q3 2022	6	$781m	n.a.	n.a.
Q4 2022	6	$840m	n.a.	n.a.
Q1 2023	15	$720m	n.a.	n.a.
Q2 2023	21	$946m	n.a.	n.a.
Q3 2023	17	$881m	n.a.	n.a.
Q4 2023	12	$912m	5	7
Q1 2024	8	$772m	2	5
Q2 2024	13	$1.0bn	6	6
Q3 2024	12	$868m	5	6
Q4 2024	14	$1.4bn	5	6
Q1 2025	13	$951m	9	4
Q2 2025	12	$897m	10	1
Q3 2025	11	$765m	6	4
Q4 2025	13	$1.6bn	12	20
Q1 2026	14	$1.6bn	19	15
Q2 2026	10	$1.1bn	14	18

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

GMED and LLY →GMED and JNJ →GMED and VRTX →Choose a stock to compare with GMED →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own GMED, latest filings →Back to the 13F Explorer →

Provided for information purposes only, not financial advice. The holdings shown here and anything drawn from them are illustrative, produced from assumptions you control, and must not be relied on for any investment, financial or business decision. Read the full notice

Not advice, and not a recommendation. Everything L3VLUP publishes is provided for information purposes only. Nothing here is financial, investment, legal, tax or accounting advice, a personal recommendation, or an offer or solicitation to buy or sell any security or financial instrument. It takes no account of anyone’s objectives, financial situation or needs.

Not a regulated adviser. L3VLUP does not provide regulated financial services. Speak to a suitably qualified and regulated professional before acting on anything you read here.

Illustrative figures. Default values are plausible starting points chosen so a model has somewhere to begin. They are not data, not a view on any company, and not calibrated to anything. Outputs move with whatever you type in.

Third-party data. Where live figures appear they come from third parties, including public filings and market feeds. They may be delayed, incomplete, restated, mis-tagged at source or simply wrong, and their providers do not endorse or verify this page. Every figure links to where it came from. Check it there before relying on it. Past performance is not a guide to future performance.

Company names and logos. Names, tickers and logos are the trademarks of their owners and appear only to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, none of them took part in preparing the exercise, and nothing here is a statement by or about any of them. See third-party names and marks.

No warranty, and limited liability. This page is provided “as is” without warranty of any kind. To the fullest extent permitted by law, L3VLUP accepts no liability for any loss or damage arising from use of, or reliance on, anything on it. Nothing in this notice limits any liability that cannot lawfully be limited.

Full terms: Information Purposes and No Advice · Terms